INFO:

In this technical session, Creative Biolabs has invited Dr. Leyton to describe the need to develop a more precise method in investigating nuclear transport dynamics of NLS-therapeutics. Moreover, Dr. Leyton will also present a de novo approach for generating novel NLSs with an atypical zero net-charge and evaluating various strategies to determine the worth for integration into NLS-therapeutics development. https://www.creative-biolabs.com/adc/webinar-novel-design-strategies-for-effective-next-generation-nuclear-localization-signal-nls-therapeutics.htm